Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Henry Schein, Inc. (HSIC)

84.96 +0.71 (+0.84%)
At close: October 28 at 4:00:00 PM EDT
84.96 0.00 (0.00%)
After hours: October 28 at 4:39:33 PM EDT
Trade HSIC on Coinbase
Chart Range Bar
Loading chart for HSIC

What's happening with HSIC?

23m ago
Powered by Yahoo Scout

Henry Schein is approaching its November 3, 2026, third-quarter earnings releasewith expectations for higher revenue but lower earnings per share. Investors are focused on profit resilience, margin-improvement plans, technology demand, and the upcoming chief financial officer transition. HSIC is up 0.84% in the current regular-session change.

Powered by Yahoo Scout
  • Previous Close 84.25
  • Open 84.10
  • Bid 77.89 x 200
  • Ask 84.88 x 100
  • Day's Range 83.97 - 85.57
  • 52 Week Range 62.15 - 92.18
  • Volume 934,462
  • Avg. Volume 1,175,853
  • Market Cap (intraday) 9.468B
  • Beta (5Y Monthly) 0.84
  • PE Ratio (TTM) 24.77
  • EPS (TTM) 3.43
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 96.87
  • Motley Fool Rating Bullish

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

www.henryschein.com

25,000

Full Time Employees

December 27

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HSIC
12.41%
S&P 500 (^GSPC)
13.13%

1-Year Return

HSIC
34.41%
S&P 500 (^GSPC)
12.38%

3-Year Return

HSIC
27.93%
S&P 500 (^GSPC)
88.08%

5-Year Return

HSIC
12.50%
S&P 500 (^GSPC)
68.48%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 3.46B
Earnings 94M
Profit Margin 2.72%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
2.8%
2.9%
3.0%
3.1%

Analyst Insights

View More

Analyst Price Targets

64.00 Low
96.87 Average
84.96 Current
110.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/14/2026
Analyst Leerink Partners
Rating Action Maintains
Rating Market Perform
Price Action Lowers
Price Target 96 -> 92

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.96%

  • Return on Assets (ttm)

    4.39%

  • Return on Equity (ttm)

    8.85%

  • Revenue (ttm)

    13.6B

  • Net Income Avi to Common (ttm)

    403M

  • Diluted EPS (ttm)

    3.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    157M

  • Total Debt/Equity (mrq)

    80.73%

  • Levered Free Cash Flow (ttm)

    446M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: